NCT00766324 2014-05-28PHA-739358 for Treatment of Hormone Refractory Prostate CancerNerviano Medical SciencesPhase 2 Completed118 enrolled
NCT00872300 2014-05-28PHA-739358 for the Treatment of Multiple MyelomaNerviano Medical SciencesPhase 2 Terminated7 enrolled
NCT00335868 2013-12-18PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL TherapyNational Cancer Institute (NCI)Phase 2 Unknown16 enrolled